Alaunos Therapeutics, Inc. (TCRT)
US Markets · Healthcare · Biotechnology
$2.26
+2.26%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$6.9M
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.